connecticut medicaid glp-1 weight loss coverage 2025 KFF's survey of officials found 16 state Medicaid programs covered GLP-1s for obesity treatment as of October 2025. Since then, four states (CA, NH, PA, SC) have ended and NC Novo Nordisk fights to keep

Every threshold, every exception, every loophole that matters

These differ from TRT, which provides exogenous testosterone and can suppress natural production if dosed in excess

How GLP-1 Medications Are Currently Administered in the UK In the UK, GLP-1 receptor agonists are available in two main formulations : subcutaneous injections and oral tablets

Individuals who are overweight or obese Patients with insulin resistance or prediabetes Those who havent succeeded with diet and exercise alone Individuals seeking optimal aesthetic results before or after procedures like liposuction, body contouring, or sculpting treatments Ready to transform your body safely and effectively